Gangagen

Develop drugs for the prevention and treatment of bacterial infections that are resistant to antibiotics

placeBengaluru, Karnataka, India calendar_todayFounded 2000 groups37 employees language gangagen.com

Registered entities

Innovation

14 patent families (8 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 1,124 times.

YearFilings
20123
20133
20144
20156
20164
20176
20184
20194
20202
20221

Social engagement

Social engagement: 4.2K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital120%
Accelerator & incubator120%
Other / undisclosed360%

Recent activity

15 Jun 2026
Milestone
regulatory
3 Mar 2026
Event
10th Annual CRID Meeting on Antimicrobial Resistance
28 Dec 2025
Recognition
Coming soon